Just announced: OpenAI plans to lease a 9.2 gigawatt 100% fossil-fuelled data centre on Ohio.
Its emissions will be between 20 - 37 MTCO2-e - somewhere between the total grid emissions of France -> Netherlands
As much GHGs as 9.5 average coal plants. Will raise US total emissions by 0.5%
Ketan Joshi
Our work on the political economy of adenoviral vectors is among few papers connecting the financialization of drug development to the scientific history of ebola. Important context for thinking critically about which players are on the scene responding to the current outbreak. @cmorten.bsky.social
The first opinion of the morning is in Hikma Pharmaceuticals v. Amarin Pharma. A unanimous court holds that Amarin, a drug maker, has failed to state a claim for active infringement of its patent.
www.supremecourt.gov/opinions/25p...
A horrifying new Ebola outbreak is underway. There's no approved vaccine for the new strain causing the outbreak.
@sariahmed.bsky.social @mattherder.bsky.social Janice Graham & I published a paper last year on the history of J&J's Ebola vaccine—and why it divested in 2023 from new vaccine research.
Community forum on Thursday morning now with eight (8!) candidates for NY12 now confirmed! Join @prep4allnow.bsky.social, @nyuengelberg.org & me for a discussion of the future of HIV care & prevention!
Free and open to all!
At @lgbtcenternyc.bsky.social!
The event will take place in person at The LGBT Community Center (@lgbtcenternyc.bsky.social)!
Registration link: www.eventbrite.com/e/community-...
Associate professor of law at @nyulaw.bsky.social. Director of the Science, Health & Information Clinic (SHIC). He/him. https://chrismorten.com/
Chris Morten
www.supremecourt.gov
Chris Morten
Exploring options for expanding PrEP access and strengthening prevention infrastructure.
Read our work in Social Science & Medicine on vectors, "platforms," and the political economy of vaccine development as it relates to J&J's adenoviral vector. Health research systems can be built to understand and solve public health problems, but that's not what we observed here unfortunately. 1/
Read our work in Social Science & Medicine on vectors, "platforms," and the political economy of vaccine development as it relates to J&J's adenoviral vector. Health research systems can be built to understand and solve public health problems, but that's not what we observed here unfortunately. 1/
karim
karim
New paper!
Karim Sariahmed, Janice E. Graham, Matthew Herder & Christopher J. Morten, Public Sector Innovation and the Constraints of “Platform Thinking”: An Account of Johnson & Johnson’s Viral Vector Vaccines, 387 Social Science & Medicine 118687 (2025).
www.sciencedirect.com/science/arti...
1/
New paper!
Karim Sariahmed, Janice E. Graham, Matthew Herder & Christopher J. Morten, Public Sector Innovation and the Constraints of “Platform Thinking”: An Account of Johnson & Johnson’s Viral Vector Vaccines, 387 Social Science & Medicine 118687 (2025).
www.sciencedirect.com/science/arti...
1/
Scholarship on political economy of vaccines in the COVID-19 era has focused on mRNA. Yet Johnson & Johnson's (J&J) vaccine based on recombinant adeno…
Scholarship on political economy of vaccines in the COVID-19 era has focused on mRNA. Yet Johnson & Johnson's (J&J) vaccine based on recombinant adeno…
Upcoming event with @nyuengelberg.org!
Community Forum on HIV Care & Prevention with candidates for NY12!
Join me, @prep4allnow.bsky.social's Jeremiah Johnson & candidates for a conversation on protecting and expanding PrEP access and strengthening HIV infrastructure.
Thursday May 14 10 am-noon!
Upcoming event with @nyuengelberg.org!
Community Forum on HIV Care & Prevention with candidates for NY12!
Join me, @prep4allnow.bsky.social's Jeremiah Johnson & candidates for a conversation on protecting and expanding PrEP access and strengthening HIV infrastructure.
Thursday May 14 10 am-noon!
